CSANZ 2021

Sponsored Symposia

Friday 6 August, 0800-0845 hrs

 


"Implementation and Best Practice Management in CVD"

Synopsis: Implementation science is recognised as critical for the systematic uptake of evidence-based practices and guideline-recommended treatments into routine clinical practice. Here we discuss the role of implementation science in the best practice management of CVD.
Speakers: Dr Andrew Black and Prof Gerald Watts

Click here to view program and speaker details.

 

"Emerging data on the link between influenza and cardiovascuar disease"

Speakers: Prof Garry Jennings and Prof Tim Tan
Chair: Dr Robert Menzies
Agenda:
Dr Rob Menzies - Intro
Prof Garry Jennings - "The link between CVD and Influenza"|
Prof Tim Tan - "Does influenza vaccination reduce the risk of CVD?"
Q&A

Synopsis:  The association between influenza infection and influenza-related cardiovascular complications has been demonstrated, with some studies showing the efficacy of influenza vaccination in reducing the risk of influenza-related cardiac events following influenza infection.1–3 Since 2018, enhanced influenza vaccines have been introduced in Australia for adults over 65.4
Hear from our speakers as they present the latest evidence and upcoming studies on the efficacy and effectiveness of influenza vaccines in preventing cardiovascular complications following influenza infection.5,6

References:
1. World Health Organization. Global Influenza Strategy 2019–2030. Available at: http://apps.who.int/iris/bitstream/handle/10665/311184/9789241515320-eng.pdf?sequence=18. Accessed 21 July 2021.
2. Warren-Gash C et al. Eur Respir J 2018;51(3):1701794.
3. Kwong et al. N Engl J Med 2018;378(4):345–353.
4. Australian Technical Advisory Group on Immunisation (ATAGI). Statement on the administration of seasonal influenza vaccines in 2018. Available at: https://www.health.gov.au/sites/default/files/atagi_clinical_advice_factsheet_-_2018_influenza_statement.pdf. Accessed 21 July 2021.
5. Udell JA et al. JAMA 2013;310(16):1711–1720.
6. Clar C et al. Database Syst Rev 2015;(5):CD005050.

Click here to view program and speaker details.

 

Friday 6 August, 1245-1330 hrs

 
"Cre8 EVO DES 1 year outcomes in complex PCI with case examples"

Synopsis:  TBC
Speakers: Scott Harding, Wellington Hospital, NZ

Click here to view program and speaker details.

 

"Durability matters for initial valve selecton"

Synopsis:  Please join us at the Medtronic Lunchtime Symposia ANZET on Friday 6 August intended to provide you with information on why durability matters for initial valve selection.
Topics:
1. Durability matters for initial valve selection
2. Rountable: Critical issues for the Low Risk patient
Chair: Prof Darren Walters, Interventional Cardiologist, AU
Speaker: Dr Sanjeevan Pasupati, Interventional Cardiologist, NZ
Panellist: Dr Robert Gooley, Interventional Cardiologist, AU

Click here to view program and speaker details.

Saturday 7 August, 1215-1300 hrs

"Heart Failure: Defining Chaos!"

Synopsis:  Understanding new definitions of heart failure
Speaker: Carmine Depasquale

Click here to view program and speaker details.

 

"Deploy, Lock, Release. Technique considerations and case examples with the GORE® CARDIOFORM Septal Occluder" 

Speakers: Dr Peter Fahmy and Associate Professor Ross Sharpe
Synopsis: In this webinar, A/Prof Ross Sharpe and Dr Peter Fahmy will review general device features and benefits of the GORE® CARDIOFORM Septal Occluder and PFO closure procedural aspects. They will also review PFO closure cases utilising the GORE® CARDIOFORM Septal Occluder.

Click here to view program and speaker details.

 

"Pulmonary Hypertension"

Speakers: A/Prof Eugene Kotlyar and Dr Rachael Cordina
Presentation 1: Update on Pulmonary Arterial Hypertension (Group 1 pulmonary hypertension)
Presentation 2: Pulmonary hypertension in the setting of congenital heart disease

Click here to view program and speaker details.